1.3(top 50%)
impact factor
878(top 20%)
papers
11.7K(top 20%)
citations
45(top 20%)
h-index
1.3(top 50%)
extended IF
949
all documents
12.1K
doc citations
59(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Bifunctional chelates for metal nuclidesQuarterly Journal of Nuclear Medicine and Molecular Imaging2008102
2Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of MilanQuarterly Journal of Nuclear Medicine and Molecular Imaging2011101
3Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytomaQuarterly Journal of Nuclear Medicine and Molecular Imaging200899
4Prostate-specific membrane antigen as a target for cancer imaging and therapyQuarterly Journal of Nuclear Medicine and Molecular Imaging201592
5Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapyQuarterly Journal of Nuclear Medicine and Molecular Imaging200487
6Labeled leukocyte imaging: current status and future directionsQuarterly Journal of Nuclear Medicine and Molecular Imaging200987
7Dosimetry for treatment with radiolabelled somatostatin analogues. A reviewQuarterly Journal of Nuclear Medicine and Molecular Imaging201085
8Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesionsQuarterly Journal of Nuclear Medicine and Molecular Imaging201084
9Biological subtypes of breast cancer: current concepts and implications for recurrence patternsQuarterly Journal of Nuclear Medicine and Molecular Imaging201384
10New PET radiopharmaceuticals beyond FDG for brain tumor imagingQuarterly Journal of Nuclear Medicine and Molecular Imaging201282
11Diagnosis and therapy of neuroendocrine tumoursQuarterly Journal of Nuclear Medicine and Molecular Imaging201076
12Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked readingQuarterly Journal of Nuclear Medicine and Molecular Imaging201176
13A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter wordsQuarterly Journal of Nuclear Medicine and Molecular Imaging200475
14Imaging reporter genes for cell tracking with PET and SPECTQuarterly Journal of Nuclear Medicine and Molecular Imaging200571
15Lung metastases from differentiated thyroid carcinoma. A 40 years' experienceQuarterly Journal of Nuclear Medicine and Molecular Imaging200468
16Imaging of infectious diseases using [18F] fluorodeoxyglucose PETQuarterly Journal of Nuclear Medicine and Molecular Imaging200866
17Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imagingQuarterly Journal of Nuclear Medicine and Molecular Imaging200866
18Conventional and advanced magnetic resonance imaging in patients with high-grade gliomaQuarterly Journal of Nuclear Medicine and Molecular Imaging201863
19Diagnostic flowcharts in osteomyelitis, spondylodiscitis and prosthetic joint infectionQuarterly Journal of Nuclear Medicine and Molecular Imaging201463
20Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumorsQuarterly Journal of Nuclear Medicine and Molecular Imaging200861
21CT radiomics and PET radiomics: ready for clinical implementation?Quarterly Journal of Nuclear Medicine and Molecular Imaging201958
22Assessing tumor hypoxia by positron emission tomography with Cu-ATSMQuarterly Journal of Nuclear Medicine and Molecular Imaging200956
23Radioimmunotherapy with alpha-particle emitting radionuclidesQuarterly Journal of Nuclear Medicine and Molecular Imaging200455
24Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patientsQuarterly Journal of Nuclear Medicine and Molecular Imaging201055
25The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literatureQuarterly Journal of Nuclear Medicine and Molecular Imaging200654
26Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre studyQuarterly Journal of Nuclear Medicine and Molecular Imaging201154
27Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary siteQuarterly Journal of Nuclear Medicine and Molecular Imaging200653
28Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from "open and see" to "see and open"Quarterly Journal of Nuclear Medicine and Molecular Imaging201453
29Nuclear imaging in cancer theranosticsQuarterly Journal of Nuclear Medicine and Molecular Imaging200752
30MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?Quarterly Journal of Nuclear Medicine and Molecular Imaging200852
31Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalitiesQuarterly Journal of Nuclear Medicine and Molecular Imaging200651
32The many ways to myocardial perfusion imagingQuarterly Journal of Nuclear Medicine and Molecular Imaging200550
33Advances in cancer therapy with radiolabeled monoclonal antibodiesQuarterly Journal of Nuclear Medicine and Molecular Imaging200650
34In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart diseaseQuarterly Journal of Nuclear Medicine and Molecular Imaging200750
35The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agentQuarterly Journal of Nuclear Medicine and Molecular Imaging200750
36Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastomaQuarterly Journal of Nuclear Medicine and Molecular Imaging200850
37Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PETQuarterly Journal of Nuclear Medicine and Molecular Imaging201150
38FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitisQuarterly Journal of Nuclear Medicine and Molecular Imaging200949
39Advances in radioguided surgery in oncologyQuarterly Journal of Nuclear Medicine and Molecular Imaging201748
40Immunoscore and its introduction in clinical practiceQuarterly Journal of Nuclear Medicine and Molecular Imaging202048
41Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disordersQuarterly Journal of Nuclear Medicine and Molecular Imaging200848
42Multimodality imaging of hypoxia in preclinical settingsQuarterly Journal of Nuclear Medicine and Molecular Imaging201047
43MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastomaQuarterly Journal of Nuclear Medicine and Molecular Imaging200847
44Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imagingQuarterly Journal of Nuclear Medicine and Molecular Imaging200846
45Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablationQuarterly Journal of Nuclear Medicine and Molecular Imaging200846
46Small animal PET in preclinical studies: opportunities and challengesQuarterly Journal of Nuclear Medicine and Molecular Imaging200846
47Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patientsQuarterly Journal of Nuclear Medicine and Molecular Imaging201046
48Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapyQuarterly Journal of Nuclear Medicine and Molecular Imaging201146
49Radiolabelled aptamers for tumour imaging and therapyQuarterly Journal of Nuclear Medicine and Molecular Imaging200745
50Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesionsQuarterly Journal of Nuclear Medicine and Molecular Imaging200945